MDHearing Neo XS vs Signia Pure C&G IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

MDHearing Neo XS
The MDHearing Neo XS is a budget OTC hearing aid featuring an invisible-in-ear design, priced at $397. In our lab testing, it earned a C grade with a SoundScore of 2.9/5, ranking #63 of 65 devices in the OTC hearing aid category. This device presents a mixed performance profile. Its standout strength is excellent feedback handling at 5.0/5, scoring 0.46 points above the category average—meaning users should experience minimal whistling or squealing during everyday use. Own-voice comfort is also solid at 3.2/5, sitting 0.69 points above average, which suggests the device manages occlusion reasonably well for its invisible design. However, speech clarity is a significant weakness. Speech in quiet scored just 1.0/5, falling 1.77 points below the category average, while speech in noise scored 1.0/5, sitting 0.48 points below average. Music streaming scored 0.0/5, coming in 1.92 points below average—indicating this device is not suitable for audio entertainment. These low absolute scores mean users may struggle to achieve meaningful speech benefit in our standardized test conditions. The invisible-in-ear form factor and rechargeable batteries offer convenience, but buyers should weigh this against the limited speech performance. Several competitors in the same price range—including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5)—deliver substantially better sound quality. The Neo XS may appeal to those prioritizing discretion and feedback-free wear over speech clarity, but most users seeking improved communication would benefit from exploring higher-performing alternatives.
Choice

Signia Pure C&G IX
The Signia Pure C&G IX is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #22 among 39 prescription hearing aids tested. This device demonstrates notable strengths in speech clarity and feedback control. Speech in quiet scored 4.0/5, which is 0.57 points above the category average—a meaningful advantage for everyday conversations. Feedback handling achieved a perfect 5.0/5, sitting 0.28 points above the already-high category average of 4.72/5. Own-voice comfort also performed well at 3.2/5, exceeding the category average by 0.50 points. Speech in noise presents a more mixed picture. While the 2.2/5 score is technically above the category average by 0.10 points, it remains modest in absolute terms—something to consider if challenging listening environments are a priority. Music streaming scored a solid 3.0/5, sitting 0.24 points above average. The Pure C&G IX features rechargeable batteries and supports streaming to both iPhone and Android devices, including hands-free calling. At this premium price point, competitors like the Phonak Sphere Infinio (4.98/5) and Oticon Intent (4.83/5) achieve higher overall scores. This device may suit those who prioritize clear speech in quieter settings and excellent feedback stability, though buyers seeking stronger noise performance may want to compare alternatives.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit